We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+10.88%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.5B
AUM Growth
-$92.3M
(-5.8%)
Cap. Flow
-$196M
Cap. Flow
% of AUM
-13.12%
Top 10 Holdings %
Top 10 Hldgs %
47.1%
Holding
47
New
6
Increased
18
Reduced
8
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$54.9M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$52.1M |
| 3 |
Zoetis
ZTS
|
+$26.3M |
| 4 |
Eli Lilly
LLY
|
+$26.1M |
| 5 |
Humana
HUM
|
+$20M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$62.7M |
| 2 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$60.6M |
| 3 |
PNK
Pinnacle Entertainment Inc.
PNK
|
+$50.6M |
| 4 |
General Motors
GM
|
+$48.9M |
| 5 |
ECOM
CHANNELADVISOR CORPORATION
ECOM
|
+$46.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.13% |
| 2 | Financials | 11.72% |
| 3 | Consumer Discretionary | 8.01% |
| 4 | Communication Services | 5.8% |
| 5 | Energy | 4.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Labcorp
LH
$25.2B
| $80.6M | 5.39% |
744,287
+182,116
| +32% | +$18.7M |
|
|
2
Zoetis
ZTS
$32B
| $78.5M | 5.25% |
1,695,228
+583,366
| +52% | +$26.3M |
|
|
OPLN
3
Openlane
OPLN
$4.2B
| $76.4M | 5.11% |
5,320,264
-1,020,536
| -16% | -$13.8M |
|
4
Morgan Stanley
MS
$334B
| $71.4M | 4.77% |
2,000,000
| – | – |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $69.8M | 4.67% |
234,562
| – | – |
|
6
Assured Guaranty
AGO
$3.69B
| $69.6M | 4.65% |
2,638,300
+288,300
| +12% | +$7.45M |
|
7
Cardinal Health
CAH
$53.6B
| $67.3M | 4.5% |
745,592
+131,535
| +21% | +$11.3M |
|
8
UnitedHealth
UNH
$383B
| $67.1M | 4.49% |
567,605
+51,365
| +10% | +$5.7M |
|
9
Alnylam Pharmaceuticals
ALNY
$27.3B
| $65.4M | 4.37% |
626,758
+62,319
| +11% | +$6.32M |
|
|
10
Marathon Petroleum
MPC
$91B
| $58.5M | 3.91% |
+1,142,724
| New | +$54.9M |
|
|
MNK
11
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $57.7M | 3.86% |
+455,405
| New | +$52.1M |
|
|
MDCO
12
DELISTED
Medicines Co
MDCO
| $54.7M | 3.66% |
1,953,133
-1,178,051
| -38% | -$33.1M |
|
13
Post Holdings
POST
$4.17B
| $53.9M | 3.6% |
1,757,683
+274,264
| +18% | +$8.38M |
|
|
14
Humana
HUM
$44.6B
| $53.6M | 3.58% |
301,224
+126,334
| +72% | +$20M |
|
15
Meta Platforms (Facebook)
META
$1.39T
| $47.3M | 3.16% |
575,000
| – | – |
|
|
LNW
16
DELISTED
Light & Wonder
LNW
| $43.4M | 2.9% |
4,147,820
| – | – |
|
17
Charter Communications
CHTR
$17.3B
| $39.5M | 2.64% |
204,423
-76,051
| -27% | -$13.2M |
|
18
Centene
CNC
$30.6B
| $37.3M | 2.5% |
1,056,352
+20,864
| +2% | +$627K |
|
19
Accuray
ARAY
$31.1M
| $36.3M | 2.43% |
3,903,090
+115,830
| +3% | +$922K |
|
20
HCA Healthcare
HCA
$86.1B
| $34.7M | 2.32% |
460,862
-258,972
| -36% | -$18.6M |
|
21
PennyMac Financial
PFSI
$3.9B
| $34.4M | 2.3% |
2,025,000
+100,000
| +5% | +$1.78M |
|
22
TG Therapeutics
TGTX
$8.01B
| $31.8M | 2.12% |
2,051,821
+271,283
| +15% | +$4.11M |
|
|
23
Eli Lilly
LLY
$1.02T
| $26.7M | 1.78% |
+366,893
| New | +$26.1M |
|
24
Tenet Healthcare
THC
$20.3B
| $26.1M | 1.74% |
527,088
+17,768
| +3% | +$831K |
|
|
25
Teva Pharmaceuticals
TEVA
$40.6B
| $25.3M | 1.69% |
406,756
-1,078,244
| -73% | -$62.7M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q1 2015 Portfolio in Review
As of Q1 2015, Bridger Management held 47 positions worth $1.5B, down 5.8% from $1.59B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Bridger Management withdrew a net $196M in Q1 2015, closing 9 positions and reducing 8 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $60.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 50% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Bridger Management opened a new position in Marathon Petroleum worth $58.5M.
- Bridger Management's largest Q1 2015 buy was Marathon Petroleum: 1,142,724 shares worth $58.5M.
- Bridger Management added most to Zoetis in Q1 2015, an estimated $26.3M increase.
- Bridger Management's biggest Q1 2015 reduction was Teva Pharmaceuticals, cutting an estimated $62.7M.
- Bridger Management fully exited Envision Healthcare Holdings Inc in Q1 2015, selling an estimated $60.6M.
- Bridger Management's ten largest holdings make up 47% of its $1.5B portfolio in Q1 2015.
- Bridger Management opened 6 new positions and closed 9 in Q1 2015.
- Bridger Management's portfolio value fell 5.8% quarter-over-quarter to $1.5B.
Based on Bridger Management's 13F filing for Q1 2015, filed 15 May 2015.